Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations

OpT2mise Study Group

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)816-818
Number of pages3
JournalDiabetes Technology and Therapeutics
Volume16
Issue number11
DOIs
StatePublished - 2014
Externally publishedYes

Cite this